bupropion hydrochloride (xl)

Generic: bupropion hydrochloride

Labeler: bryant ranch prepack
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride (xl)
Generic Name bupropion hydrochloride
Labeler bryant ranch prepack
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 300 mg/1

Manufacturer
Bryant Ranch Prepack

Identifiers & Regulatory

Product NDC 71335-1114
Product ID 71335-1114_99d9c657-4add-4f6e-8c5d-75d888473e23
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210081
Listing Expiration 2026-12-31
Marketing Start 2018-08-30

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 713351114
Hyphenated Format 71335-1114

Supplemental Identifiers

RxCUI
993557
UNII
ZG7E5POY8O

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (xl) (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA210081 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-1)
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-2)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-3)
  • 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-4)
  • 8 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-5)
  • 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-6)
source: ndc

Packages (6)

Ingredients (1)

bupropion hydrochloride (300 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "99d9c657-4add-4f6e-8c5d-75d888473e23", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["64be3113-837a-48f3-9f9e-400529c9ee94"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-1)", "package_ndc": "71335-1114-1", "marketing_start_date": "20190222"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-2)", "package_ndc": "71335-1114-2", "marketing_start_date": "20240905"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-3)", "package_ndc": "71335-1114-3", "marketing_start_date": "20190221"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-4)", "package_ndc": "71335-1114-4", "marketing_start_date": "20190329"}, {"sample": false, "description": "8 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-5)", "package_ndc": "71335-1114-5", "marketing_start_date": "20240905"}, {"sample": false, "description": "180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-6)", "package_ndc": "71335-1114-6", "marketing_start_date": "20240905"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "71335-1114_99d9c657-4add-4f6e-8c5d-75d888473e23", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71335-1114", "generic_name": "bupropion hydrochloride", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA210081", "marketing_category": "ANDA", "marketing_start_date": "20180830", "listing_expiration_date": "20261231"}